Last $336.79 USD
Change Today -0.81 / -0.24%
Volume 1.6M
BIIB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 8:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven H. Holtzman D.Phil.

Executive Vice President of Corporate Development, Biogen Idec Inc.
AgeTotal Calculated CompensationThis person is connected to 120 board members in 4 different organizations across 9 different industries.

See Board Relationships
60--

Background*

Mr. Steven H. Holtzman, also known as Steve, D.Phil., has been an Executive Vice President of Corporate Development at Biogen Idec Inc. since January 5, 2011. Mr. Holtzman has substantial experience in building collaborations with major pharmaceutical companies and licensing products. He founded Infinity Pharmaceuticals Inc. in 2006 and served as its Executive Chairman and also served as its Non-Executive Chairman since December 31, 2010, Chairman of the Board from September ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 781-464-2000
Fax: --

Board Members Memberships*

Former Director
Founder
Director
2004-2011
Former Chairman of the Board and Chairman of Compensation Committee
2009-Present
Chairman
2014-Present
Director
2014-Present
Director

Education*

BA
Michigan State University
PhB
University of Oxford
PhD
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $336.79 USD -0.81

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Robert J. Hugin MBAChairman, Chief Executive Officer, President and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN IDEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.